Tentang podcast ini
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
Episode
20 episode terbaru dari 63
- Making the Move to AAV producer cell lines: comparability, bridging studies and regulatory considerations · 29 mnt · Musim 5 Episode 5Lauren Coyle (Editor, BioInsights) speaks with Lonza's Laura Sands (Head of Regulatory Affairs), Ramesh Koukuntla (Director of R&D), Wenling Dong (Head of Upstream Process…
- From one target to many: how high‑plex ddPCR is changing CGT from development to analytics · 15 mnt · Musim 5 Episode 4Lauren Coyle, Editor, BioInsights, speaks with Christian Overgaard, Senior Field Application Scientist, Bio‑Rad Laboratories, about the technical and practical evolution of…
- Beyond one and done: engineering durable, redosable cell‑based gene therapies · 19 mnt · Musim 5 Episode 3The one‑and‑done model has defined gene therapy for a generation. Chris Hopkins thinks it is time to move on. At ASGCT 2026, Abi Pinchbeck spoke with the Co‑founder and CEO of…
- Precision by design: engineering site‑specific ADCs with machine learning · 24 mnt · Musim 5 Episode 2Lauren Coyle, Launch Commissioning Editor, Bioconjugate Insights, speaks with Weston Kightlinger, CEO, Ridge Bio, about the challenge of DAR heterogeneity and site specificity in…
- Crossing the ADC inflection points: what separates clinical success from failure · 30 mnt · Musim 5 Episode 1Lauren Coyle, Launch Commissioning Editor, Bioconjugate Insights, speaks with Antoine Yver, Board Chair, Ona Therapeutics, with more than three and a half decades of experience…
- Formulation and delivery of RNA-based vaccines and therapeutics: addressing outstanding questions around safety and purity · 24 mnt · Musim 4 Episode 8In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety…
- Advancing nucleic acid therapeutics with circular RNA · 34 mnt · Musim 4 Episode 7In this podcast episode, Jokūbas Leikauskas, Editor, BioInsights, speaks to Trevor Hallam, who served as Chief Scientific Officer of Sail Biomedicines until July 2025. The…
- Exploring advances in bioconjugation: nanozymes, tissue tropism, and the future of responsive systems · 15 mnt · Musim 4 Episode 6Lauren Coyle (Commissioning Editor, Bioconjugation Insights) speaks to Vincent Rotello (Distinguished Professor of Chemistry, University of Massachusetts Amherst) about the…
- The promise of antibody-oligonucleotide conjugates for neurological diseases · 21 mnt · Musim 4 Episode 5Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, speaks with Kerstin Hofer, Science and People Lead, Roche, about the evolving application of…
- From innovation to access: bridging gaps in scalability and cold chain precision logistics for advanced therapies · 20 mnt · Musim 4 Episode 4Jokūbas Leikauskas, Editor, BioInsights, speaks to Rohin Iyer, Senior Director, Global Cell and Gene Therapy Operations, Marken, about addressing the complex logistics of cell…
- Enhancing mRNA results through strategic RNA design and quality control · 13 mnt · Musim 4 Episode 3In the last few years, mRNA has moved to the fore in the vaccine and cell and gene therapy fields, and as a result, its successful production for these downstream applications…
- For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications · 19 mnt · Musim 4 Episode 2Roisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Stanley Crooke, Chairman, Founder and CEO, n-Lorem, about his long career and pioneering role in the…
- Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space · 15 mnt · Musim 4 Episode 1Róisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Ketaki Deshmukh, Senior Scientist, Novo Nordisk, about advanced characterization tools for LNPs…
- Driving innovation in cell and gene therapy: the role of AI and robotics · 16 mnt · Musim 3 Episode 12Jokūbas Leikauskas, Editor, Cell & Gene Therapy Insights, speaks with OmniaBio Inc.’s Kenneth Harris, Chief Strategy Officer and Head of AI, Mitchel Sivilotti, President and CEO…
- Spatial mapping: shaping the future of I-O diagnostics and treatment · 39 mnt · Musim 3 Episode 11Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Banafshé Larijani, Director of the Centre for Therapeutic Innovation, University of Bath, about the…
- Pioneering quality control in biomanufacturing of cell and gene therapies · 28 mnt · Musim 3 Episode 10Lauren Coyle, Commissioning Editor, speaks with Dhruv Sareen, Executive Director at Cedars-Sinai Biomanufacturing Center, and Johnathan Rodriguez, Quality Control Manager at…
- Preparing for tomorrow’s cell and gene therapies today: lessons from 30 years in the field · 26 mnt · Musim 3 Episode 9For the first time in history, cell and gene therapy products are reaching the market in waves rather than in one’s and two’s, creating unprecedented challenges for…
- Insights into advanced therapies in the context of evolving funding and M&A environments · 23 mnt · Musim 3 Episode 8David McCall, Senior Editor, BioInsights, spoke to Lee Brown, Healthcare Sector Global Team Leader, Third Bridge Group, on Tuesday, February 6, 2024 to gain his insights into the…
- Fit for function: developing potency assays reflective of the in vivo environment · 28 mnt · Musim 3 Episode 7Translating the therapeutic promise of cell and gene therapies into clinical reality relies on robust potency assays. However, designing assays that accurately reflect the…
- Gene therapy is having a monumental year: how can the industry keep up with supply? · 24 mnt · Musim 3 Episode 6Lauren Coyle, Commissioning Editor, Cell & Gene Therapy Insights, talks with Suman Subramanian, Head of Commercial Operations, Catalent Cell and Gene Therapy, to discuss the…







